|
Home > Offers to Sell > Chemicals & Plastics > Pharmaceutical Chemicals > Pharmaceutical Intermediates
Contact: |
Echo-wingroup |
Company: |
wuhan wingroup |
|
Wuhan (Hubei), China |
|
wuhan 430000 |
|
China |
Phone: |
15797076598 |
Fax: |
86-27-87819568 |
E-Mail: |
|
|
|
Date/Time: |
10/24/22 8:43 GMT |
|
|
2-Benzylamino-2-methyl-1-propanol cas10250-27-8 made in china
Product Name: 2-Benzylamino-2-methyl-1-propanol Synonyms: 2-Benzylamino-2-methyl-1-propanol;2-Methyl-2-[(phe , nylmethyl)amino]-1- propanol;(Benzyl)(2-hydroxy , -1,1-dimethylethyl)amine;2-(benzylamino)-2-methyl- , 1- propanol(SALTDATA: HCl);BMK GLYCIDATE FACTORY;New bmk glycidate powder;2- Benzylamino-2-methyl-1-propano;1-Prop , anol, 2-methyl-2-[(phenylmethyl)amino]- CAS NO.: 10250-27-8 Purity: 99% Molecular Formula: C11H17NO Molecular Weight: 179.26 Appearance: White Crystal powder
Hot Selling 1 CAS NO Name 2 110-63-4 1,4-Butanediol 3 584-03-2 1,2-butanediol 4 872-50-4 N-Methyl-2-pyrrolidone (NMP) 5 110-64-5 2-Butene-1,4-diol 6 7331-52-4 (S)-3-Hydroxy-gamma-butyrolactone 7 517-23-7 a-Acetobutyrolactone 8 28578-16-7 PMK ethyl glycidate (PMK powder&oil) 9 20320-59-6 Diethyl(phenylacetyl)malonate (New BMK oil ) 10 5449-12-7 BMK Glycidic Acid (sodium salt) 11 80532-66-7 BMK Methyl Glycidate 12 25547-51-7 BMK Glycidic Acid 13 10250-27-8 2-Benzylamino-2-methyl-1-propanol 14 16648-44-5 BMK glycidate/Methyl 2-phenylacetoacetate 15 5337-93-9 4-Methylpropiophenone 16 1451-82-7 2-bromo-4-methylpropiophenone 17 1009-14-9 Valerophenone 18 925-90-6 Ethylmagnesium Bromide 19 86-29-3 Diphenylacetonitrile 20 49851-31-2 2-BROMO-1-PHENYL-PENTAN-1-ONE 21 124878-55-3 2-iodo-1-phenylpentan-1-one 22 2079878-75-2 2-(2-Chlorophenyl)-2-nitrocyclohexanone 23 3900-45-6 2-Acetyl-6-methoxynaphthalene 24 71368-80-4 Bromazolam
Wuhan Wingroup Pharmaceutical Co.,Ltd Echo Xiong (sales manager) Wickr:echo1020 TEL:+86-27-87819568
Minimum Order: 1 kilograms
Click to Enlarge
SOURCE: Import-Export Bulletin Board (https://www.imexbb.com/)
Post an Offer to Sell
© 1996-2010 IMEXBB.com. All rights reserved.
|
|